Tom K Birkenhager

9PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsEpidemiological modellingMolecular medicineCancer therapy (excl. chemotherapy and radiation therapy)Behavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 24, 2026
Imipramine: Do Metabolite Plasma Levels Affect Treatment Response?

|Sep 03, 2024
Monoamine oxidase inhibitors: Seriously underused in the treatment of major depression.

Tom K Birkenhager, Willemijn T Heijnen

|Mar 20, 2023
Clinical characteristics associated with relapse 2 years after electroconvulsive therapy for major depression.

Esther M Pluijms, Poul T Vinther, Astrid M Kamperman

|Feb 13, 2022
Influence of adjuvant nortriptyline on the efficacy of electroconvulsive therapy: A randomized controlled trial and 1-year follow-up.

Esther M Pluijms, Astrid M Kamperman, Witte J G Hoogendijk

|Sep 08, 2020
Cognitive change after electroconvulsive therapy in mood disorders measured with the Montreal Cognitive Assessment.

K Hebbrecht, E J Giltay, T K Birkenhäger

Pageof 2